Nucleic acid extractions for dceg studies
Ended Awarded Last action
- Contract number
- 75N91022F00002
- Awardee
-
Research Institute At Nationwide Children's Hospital UEI EYMJXLN2MFB4 Part of Nationwide Childrens Hospital
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $631,506
Award facts
- Contract value 57% obligated
-
- $631,506.00 Current, with exercised options
- $1,112,184.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Columbus, OH 43205, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $53,056 | |
| Exercise an Option | $14,109 | |
| Exercise an Option | $172,427 | |
| Exercise an Option | $201,418 | |
| Original award | $190,496 |
About this award
This is a $1,112,184.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Research Institute at Nationwide Children's Hospital, a non-profit research organization. The contract is for nucleic acid extractions and biospecimen core resource services to support studies conducted by NCI's Division of Cancer Epidemiology and Genetics (DCEG). The award has an ultimate completion date of August 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the Research Institute at Nationwide Children's Hospital with the Health Resources and Services Administration (HRSA), which primarily supports the Advisory Committee on Heritable Disorders in Newborns and Children. The contract does not have a set-aside designation, indicating it was competed on the open market.
Quick answers
Who was awarded contract 75N91022F00002?
75N91022F00002 was awarded to Research Institute At Nationwide Children's Hospital by National Cancer Institute (National Institutes of Health) on September 16, 2022.
How much is contract 75N91022F00002 worth?
The government has obligated $631,506 on 75N91022F00002. Its potential value, with all options, is $1,112,184.
Is contract 75N91022F00002 an order under another contract?
Yes. 75N91022F00002 is a delivery order under HHSN261201700015I, an indefinite delivery contract.
Was contract 75N91022F00002 competed?
The extent of competition for 75N91022F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award